<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="33300">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01698619</url>
  </required_header>
  <id_info>
    <org_study_id>AconcaguaIron</org_study_id>
    <nct_id>NCT01698619</nct_id>
  </id_info>
  <brief_title>Hemodynamic Changes in Altitude Adaptation</brief_title>
  <official_title>Hemodynamic Changes in Altitude Adaptation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Goethe University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Goethe University</source>
  <oversight_info>
    <authority>Germany: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We use a new technology (Nexfin from BMEYE-Inventive Hemodynamics) to monitor Cardiac
      Output, Blood Pressure, Fluid Responsiveness, Pulse Oximetry, Hemoglobin Concentration,
      Oxygen Delivery in Climbers during their process of acclimatization on a expedition to Mount
      Aconcagua.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Several parameters will be recorded to analyze their influence on the adaptation to high
      altitude. Such as, food composition, dietary supplements, water intake and output.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2012</start_date>
  <completion_date type="Anticipated">December 2012</completion_date>
  <primary_completion_date type="Anticipated">December 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Changes from baseline in Oxygen Delivery</measure>
    <time_frame>daily, up to 18 days</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Unit: ml/min baseline measure will be obtained at sea level</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes from baseline in Hemoglobin Concentration</measure>
    <time_frame>daily, up to 18 days</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Unit: mg/dl baseline measure will be obtained at sea level</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Changes from baseline in Blood pressure, Fluid Responsiveness, Oxygen Saturation, Cardiac Output</measure>
    <time_frame>daily, up to 18 days</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>baseline measure will be obtained at sea level</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">12</enrollment>
  <condition>Acute Mountain Sickness</condition>
  <condition>High Altitude Pulmonary Edema</condition>
  <condition>High Altitude Cerebral Edema</condition>
  <arm_group>
    <arm_group_label>Climbers on Mount Aconcagua</arm_group_label>
    <description>The Cohort consists of volunteers climbing Mount Aconcagua.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        healthy volunteers taking part in an expedition to Mount Aconcagua
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  No acute or chronic disease

          -  Body mass index : 20 - 30

        Exclusion Criteria:

          -  Any preexisting disease that has a potential impact on physical performance such as:

               -  pulmonary

               -  cerebral

               -  muscular

               -  cardiac

               -  vascular - diseases
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Goethe University</name>
      <address>
        <city>Frankfurt</city>
        <state>Hessen</state>
        <zip>60590</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Stein, Dr.</last_name>
      <phone>0049 1577 6400 769</phone>
      <email>peter.stein@kgu.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>September 2012</verification_date>
  <lastchanged_date>October 2, 2012</lastchanged_date>
  <firstreceived_date>September 27, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Goethe University</investigator_affiliation>
    <investigator_full_name>Peter Stein</investigator_full_name>
    <investigator_title>Consultant</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Altitude Sickness</mesh_term>
    <mesh_term>Brain Edema</mesh_term>
    <mesh_term>Edema</mesh_term>
    <mesh_term>Pulmonary Edema</mesh_term>
    <mesh_term>Hypertension, Pulmonary</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
